资讯

First-in-human trial shows promising results for antibody-drug conjugate in relapsed small ...

A first-in-human Phase I study of SHR-4849 (IDE849), a Delta-like ligand 3 (DLL3)-directed antibody-drug conjugate (ADC), ...
Manila Standard9 小时

Healthway, AstraZeneca team up to launch lung center of excellence

Healthway Cancer Care Hospital (HCCH), the country’s first specialized hospital for cancer treatment, has teamed up with ...
UNILAD3 天

Expert issues warning about possible cancer symptoms that are more likely to show up in the ...

Certain symptoms that could suggest cancer have a tendency to appear first thing in the morning, an expert has warned. While ...

Cancer Warning Signs Women Must Watch Out For, According to Doctors

Many cancers in women begin with subtle or vague signs that are often mistaken for minor health issues. Experts warn that ...
Newspoint on MSN6 天

Antibody drug shows promise against lung cancer in first human trial

Researchers has led a first-in-human trial of an antibody drug for treatment of people with relapsed small-cell lung cancer ...
The Manila Times on MSN6 小时

Healthway, AstraZeneca launch lung cancer clinic

HEALTHWAY Cancer Care Hospital of AC Health, the health care arm of the Ayala Group, has partnered with pharmaceutical firm AstraZeneca to launch a lung center that is expected to provide services ...
Medscape3 年

Revolutionary 'Death Star' Targeting Lung Cancer Drug Available on the NHS

A revolutionary life-extending drug has received approval from the National Institute for Health and Care Excellence (NICE) making it available on the NHS for patients with lung cancer. Following an ...